BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25056891)

  • 1. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.
    Bhardwaj N; Maldarelli F; Mellors J; Coffin JM
    J Virol; 2014 Oct; 88(19):11108-20. PubMed ID: 25056891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Infection of Primary CD4
    Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.
    Gonzalez-Hernandez MJ; Cavalcoli JD; Sartor MA; Contreras-Galindo R; Meng F; Dai M; Dube D; Saha AK; Gitlin SD; Omenn GS; Kaplan MH; Markovitz DM
    J Virol; 2014 Aug; 88(16):8924-35. PubMed ID: 24872592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
    Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
    J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21.
    Ruprecht K; Ferreira H; Flockerzi A; Wahl S; Sauter M; Mayer J; Mueller-Lantzsch N
    J Virol; 2008 Oct; 82(20):10008-16. PubMed ID: 18684837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.
    Flockerzi A; Ruggieri A; Frank O; Sauter M; Maldener E; Kopper B; Wullich B; Seifarth W; Müller-Lantzsch N; Leib-Mösch C; Meese E; Mayer J
    BMC Genomics; 2008 Jul; 9():354. PubMed ID: 18664271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA.
    Gray LR; Jackson RE; Jackson PEH; Bekiranov S; Rekosh D; Hammarskjöld ML
    Retrovirology; 2019 Dec; 16(1):40. PubMed ID: 31842941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.
    Contreras-Galindo R; Kaplan MH; Markovitz DM; Lorenzo E; Yamamura Y
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):979-84. PubMed ID: 17067267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide amplification of proviral sequences reveals new polymorphic HERV-K(HML-2) proviruses in humans and chimpanzees that are absent from genome assemblies.
    Macfarlane CM; Badge RM
    Retrovirology; 2015 Apr; 12():35. PubMed ID: 25927962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.
    Mayer J; Ehlhardt S; Seifert M; Sauter M; Müller-Lantzsch N; Mehraein Y; Zang KD; Meese E
    Virology; 2004 Apr; 322(1):190-8. PubMed ID: 15063128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human endogenous retrovirus HERV-K(HML-2) env expression is not associated with markers of immunosenescence.
    Marttila S; Nevalainen T; Jylhävä J; Kananen L; Jylhä M; Hervonen A; Hurme M
    Exp Gerontol; 2017 Oct; 97():60-63. PubMed ID: 28774724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of HERV-K (HML-2) proviruses in cells and virions of the teratocarcinoma cell line Tera-1.
    Bhardwaj N; Montesion M; Roy F; Coffin JM
    Viruses; 2015 Mar; 7(3):939-68. PubMed ID: 25746218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
    de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
    Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression pattern analysis of transcribed HERV sequences is complicated by ex vivo recombination.
    Flockerzi A; Maydt J; Frank O; Ruggieri A; Maldener E; Seifarth W; Medstrand P; Lengauer T; Meyerhans A; Leib-Mösch C; Meese E; Mayer J
    Retrovirology; 2007 Jun; 4():39. PubMed ID: 17550625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of HERV-K (HML-2) Transcription during Human Mammary Epithelial Cell Transformation.
    Montesion M; Bhardwaj N; Williams ZH; Kuperwasser C; Coffin JM
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells.
    Fuchs NV; Loewer S; Daley GQ; Izsvák Z; Löwer J; Löwer R
    Retrovirology; 2013 Oct; 10():115. PubMed ID: 24156636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human endogenous retrovirus family HERV-K(HML-3).
    Mayer J; Meese EU
    Genomics; 2002 Sep; 80(3):331-43. PubMed ID: 12213204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the distribution of human endogenous retroviruses K (HML-2) by PCR-based target enrichment sequencing.
    Xue B; Zeng T; Jia L; Yang D; Lin SL; Sechi LA; Kelvin DJ
    Retrovirology; 2020 May; 17(1):10. PubMed ID: 32375827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses.
    Subramanian RP; Wildschutte JH; Russo C; Coffin JM
    Retrovirology; 2011 Nov; 8():90. PubMed ID: 22067224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter expression of HERV-K (HML-2) provirus-derived sequences is related to LTR sequence variation and polymorphic transcription factor binding sites.
    Montesion M; Williams ZH; Subramanian RP; Kuperwasser C; Coffin JM
    Retrovirology; 2018 Aug; 15(1):57. PubMed ID: 30126415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.